Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Tenforde

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2026
Government to Government Model for HIV Service Delivery - An Approach for Country and Program Ownership in Four Provinces of ZambiaKeith Mweebo, Annie Mwila, Kiva F Tinglof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020Mark W Tenforde, Rebecca J Garten Kondor, Jessie R Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal MeningitisMark W Tenforde, Margaret Mokomane, Tshepo Leeme, et al.
Open Forum Infectious Diseases|October 22, 2024
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis in High-HIV Prevalence SettingsJames Milburn, Christopher G Williams, Kwana Lechiile, et al.
MMWR. Morbidity and Mortality Weekly Report|July 3, 2020
Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020Mark W Tenforde, Erica Billig Rose, Christopher J Lindsell, et al.
Journal of Clinical and Translational Science|June 20, 2022
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomesMichael J Ward, David J Douin, Wu Gong, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
Influenza and Other Respiratory Viruses|March 29, 2022
Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distressJin H Han, Kelsey N Womack, Mark W Tenforde, et al.
MMWR. Morbidity and Mortality Weekly Report|September 11, 2020
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020Kiva A Fisher, Mark W Tenforde, Leora R Feldstein, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Plos One|February 27, 2015
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W Tenforde, Nikhil Gupte, David W Dowdy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2026
Government to Government Model for HIV Service Delivery - An Approach for Country and Program Ownership in Four Provinces of ZambiaKeith Mweebo, Annie Mwila, Kiva F Tinglof, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020Mark W Tenforde, Rebecca J Garten Kondor, Jessie R Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal MeningitisMark W Tenforde, Margaret Mokomane, Tshepo Leeme, et al.
Open Forum Infectious Diseases|October 22, 2024
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis in High-HIV Prevalence SettingsJames Milburn, Christopher G Williams, Kwana Lechiile, et al.
MMWR. Morbidity and Mortality Weekly Report|July 3, 2020
Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020Mark W Tenforde, Erica Billig Rose, Christopher J Lindsell, et al.
Journal of Clinical and Translational Science|June 20, 2022
Modeling clinical trajectory status of critically ill COVID-19 patients over time: A method for analyzing discrete longitudinal and ordinal outcomesMichael J Ward, David J Douin, Wu Gong, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
Influenza and Other Respiratory Viruses|March 29, 2022
Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distressJin H Han, Kelsey N Womack, Mark W Tenforde, et al.
MMWR. Morbidity and Mortality Weekly Report|September 11, 2020
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020Kiva A Fisher, Mark W Tenforde, Leora R Feldstein, et al.
Pageof 14